| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Revenue | $679.5M | +0.4% |
| R&D Expense | $1.0M | +0.0% |
| SG&A Expense | $143.4M | -4.4% |
| Operating Income | -$139.3M | -45.6% |
| Interest Expense | $19K | -92.6% |
| Pre-tax Income | -$134.0M | -46.2% |
| Income Tax | $46K | +103.5% |
| Net Income | -$134.1M | -48.3% |
| EPS (Basic) | -$1.14 |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.2M | -58.5% |
| Accounts Receivable | $5.2M | +2.6% |
| Inventory | $2.4M | +20.0% |
| Current Assets | $129.7M | -44.7% |
| Total Assets | $788.1M | -8.0% |
| Current Liabilities | $118.7M | +2.4% |
| Total Liabilities | $432.0M | +5.2% |
| Line Item | 2025-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.7M | -129.3% |
| Capital Expenditures | $106.5M | +26.1% |
| Investing Cash Flow | -$114.3M | -23.9% |
| Financing Cash Flow | $2.9M | -67.8% |
| Free Cash Flow | -$119.2M | -190.2% |
| -44.3% |
| EPS (Diluted) | -$1.14 | -44.3% |
| Stockholders' Equity |
| $356.1M |
| -20.2% |